Question 1

What are CDKs and why are they important for cell division?

Accepted Answer

Cyclin-dependent kinases (CDKs) are regulatory proteins that control progression through the cell cycle by phosphorylating target proteins. CDKs work with cyclins to drive cells through different phases, making them essential for coordinating DNA replication and cell division. Their activity must be tightly regulated to prevent uncontrolled proliferation.

Question 2

How do CDK inhibitors work to stop cell proliferation?

Accepted Answer

CDK inhibitors block the enzymatic activity of cyclin-dependent kinases, preventing them from phosphorylating downstream target proteins. This halts cell cycle progression by preventing cells from advancing through critical checkpoints. By inhibiting CDK activity, cells cannot proceed with DNA replication or mitosis.

Question 3

What is the relationship between CDK inhibition and cancer treatment?

Accepted Answer

CDK inhibitors are used therapeutically to stop uncontrolled cancer cell division by preventing CDK-cyclin complexes from driving proliferation. Cancer cells often have dysregulated CDK activity, making them dependent on continuous cell cycle progression. Inhibiting CDKs forces cancer cells to exit the cycle or undergo apoptosis.

Question 4

Which cyclins partner with CDKs at different cell cycle stages?

Accepted Answer

Different cyclin-CDK complexes regulate specific phases: cyclin E-CDK2 controls G1/S transition, cyclin A-CDK2 drives S phase, and cyclin B-CDK1 regulates G2/M transition. Each complex activates phase-specific proteins required for DNA replication and chromosome segregation. Cyclin levels fluctuate throughout the cell cycle to ensure proper timing.

Question 5

What happens to cells when CDK activity is completely blocked?

Accepted Answer

When CDK activity is inhibited, cells cannot phosphorylate proteins needed for cell cycle progression and become arrested at specific checkpoints. Prolonged CDK inhibition triggers cell death pathways, including apoptosis, preventing damaged or abnormal cells from dividing. This mechanism is exploited in cancer therapy to eliminate rapidly dividing cells.

Question 6

How do checkpoint mechanisms use CDK inhibition to maintain genomic stability?

Accepted Answer

Cell cycle checkpoints monitor DNA integrity and activate CDK inhibitors when damage is detected, halting progression until repairs are complete. This protective mechanism prevents replication of damaged DNA and transmission of mutations to daughter cells. CDK inhibition at checkpoints is essential for maintaining genomic stability and preventing cancer development.

Hamowanie aktywności CDK

Browse More Videos